+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
NEPHROPLUS

Nephrocare Health Services Share Price

₹602.40 -6.5 (-1.07%)

22 Oct, 2026 3:31 PM (IST)

Nephrocare Health Services live price: ₹602.40. It opened at ₹602 vs previous close ₹609; intraday high/low: ₹607/₹595. The 50 & 200 DMA stand at ₹665.10/₹607.60.

Nephrocare Health Services Performance

  • Today's Low
  • ₹595
  • Today's High
  • ₹607
  • 52 Week Low
  • ₹446
  • 52 Week High
  • ₹782
  • Open Price₹602
  • Previous Close₹609
  • Volume126,543
  • 50 DMA₹665.10
  • 100 DMA₹658.30
  • 200 DMA₹607.60

Nephrocare Health Services Chart

Investment Returns

  • Over 1 Month -19.85%
  • Over 3 Month -3.85%
  • Over 6 Month + 7.09%
  • Over 1 Year + 30.96%

Smart Investing Starts Here Start SIP with Nephrocare Health Services for Steady Growth!

Invest Now

Nephrocare Health Services Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 71
  • PEG Ratio
  • -
  • Market Cap Cr
  • 6,045
  • P/B Ratio
  • 5.2
  • Average True Range
  • 19.9
  • EPS
  • 8.5
  • Dividend Yield
  • 0
  • MACD Signal
  • -25.5
  • RSI
  • 26.49
  • MFI
  • 16.75

Latest Stock News Updates

Nephrocare Health Services Ltd - 544647 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Reg 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an investor conference call as per the disclosure annexed herewith.

Nephrocare Health Services Ltd - 544647 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2026.

Nephrocare Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026.

Nephrocare Health Services Ltd - 544647 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

We are enclosing herewith a certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for quarter ended 30th September, 2026 received from M/s. KFIN Technologies Limited.

Nephrocare Health Services Financials

Nephrocare Health Services Technicals

EMA & SMA

Current Price
₹602.40
-6.5 (-1.07%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹639.80
  • 50 Day
  • ₹665.10
  • 100 Day
  • ₹658.30
  • 200 Day
  • ₹607.60

Resistance and Support

601.53 Pivot Speed
  • R3 620.40
  • R2 613.80
  • R1 608.10
  • S1 595.80
  • S2 589.30
  • S3 583.60

Nephrocare Health Services Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-03 Quarterly Results To consider and approve the financial results for the period ended September 30, 2026
2026-08-11 Quarterly Results o approve the financial results for the quarter ended June 30, 2026.
2026-05-19 Audited Results
2026-02-10 Quarterly Results

Nephrocare Health Services Shareholding Pattern

58.31%
21.85%
11.73%
4.18%
3.93%

About Nephrocare Health Services

Nephrocare Health Services has been set up for the purpose of providing dialysis healthcare services through a chain of kidney care clinics. View More
  • NSE Symbol
  • NEPHROPLUS
  • BSE Symbol
  • 544647
  • ISIN
  • INE428V01029

Similar Stocks to Nephrocare Health Services

Nephrocare Health Services FAQs

Nephrocare Health Services share price is ₹602 As on 23 October, 2026 | 05:02

The Market Cap of Nephrocare Health Services is ₹6044.5 Cr As on 23 October, 2026 | 05:02

The P/E ratio of Nephrocare Health Services is 71 As on 23 October, 2026 | 05:02

The PB ratio of Nephrocare Health Services is 5.2 As on 23 October, 2026 | 05:02

The 52 week High & Low of Nephrocare Health Services is ₹781.5/₹446 respectively As on 23 October, 2026 | 05:02

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23